NASDAQ: IPHA
Innate Pharma Sa Stock Forecast, Predictions & Price Target

Analyst price target for IPHA

Based on 2 analysts offering 12 month price targets for Innate Pharma Sa

Min Forecast
$5.00+176.24%
Avg Forecast
$6.50+259.12%
Max Forecast
$8.00+341.99%

Should I buy or sell IPHA stock?

Based on 2 analysts offering ratings for Innate Pharma Sa.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IPHA stock forecasts and price targets.

IPHA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-07
lockedlocked$00.00+00.00%2026-03-12

1 of 1

IPHA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IPHA$1.81$6.50+259.12%Strong Buy
YDES$2.42N/AN/A
NBP$1.50$9.00+500.00%Buy
TTRX$5.87$8.00+36.29%Strong Buy
HURA$2.57$9.50+269.65%Buy

Innate Pharma Sa Stock Forecast FAQ

Is Innate Pharma Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IPHA) stock is to Strong Buy IPHA stock.

Out of 2 analysts, 1 (50%) are recommending IPHA as a Strong Buy, 1 (50%) are recommending IPHA as a Buy, 0 (0%) are recommending IPHA as a Hold, 0 (0%) are recommending IPHA as a Sell, and 0 (0%) are recommending IPHA as a Strong Sell.

If you're new to stock investing, here's how to buy Innate Pharma Sa stock.

What is IPHA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IPHA price target, the average IPHA price target is $6.50, with the highest IPHA stock price forecast at $8.00 and the lowest IPHA stock price forecast at $5.00.

On average, Wall Street analysts predict that Innate Pharma Sa's share price could reach $6.50 by Apr 7, 2027. The average Innate Pharma Sa stock price prediction forecasts a potential upside of 259.12% from the current IPHA share price of $1.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.